107 related articles for article (PubMed ID: 23549167)
21. E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT.
Sommariva M; Gagliano N
Cells; 2020 Apr; 9(4):. PubMed ID: 32331358
[TBL] [Abstract][Full Text] [Related]
22. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
Guo S; Xu X; Tang Y; Zhang C; Li J; Ouyang Y; Ju J; Bie P; Wang H
Cancer Lett; 2014 Mar; 344(1):40-46. PubMed ID: 24252251
[TBL] [Abstract][Full Text] [Related]
23. Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state.
Usova EV; Kopantseva MR; Kostina MB; Van'kovich AN; Egorov VI; Kopantsev EP
Dokl Biol Sci; 2013 Jan; 448():61-4. PubMed ID: 23479023
[No Abstract] [Full Text] [Related]
24. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
[TBL] [Abstract][Full Text] [Related]
25. Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer.
Shinke G; Yamada D; Eguchi H; Iwagami Y; Asaoka T; Noda T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Cancer Sci; 2018 Aug; 109(8):2520-2531. PubMed ID: 29917299
[TBL] [Abstract][Full Text] [Related]
26. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.
Jung DE; Kim JM; Kim C; Song SY
Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma.
Babiker HM; Riaz IB; Shah SR; Von Hoff DD; Borad MJ
Anticancer Drugs; 2017 Feb; 28(2):127-132. PubMed ID: 27685167
[TBL] [Abstract][Full Text] [Related]
29. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
30. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
31. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of APC Induces CD34 Upregulation to Promote Epithelial-Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer.
Hsieh MJ; Chiu TJ; Lin YC; Weng CC; Weng YT; Hsiao CC; Cheng KH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586050
[TBL] [Abstract][Full Text] [Related]
33. Nicotine promotes tumor progression and epithelial-mesenchymal transition by regulating the miR-155-5p/NDFIP1 axis in pancreatic ductal adenocarcinoma.
Ben Q; Sun Y; Liu J; Wang W; Zou D; Yuan Y
Pancreatology; 2020 Jun; 20(4):698-708. PubMed ID: 32354626
[TBL] [Abstract][Full Text] [Related]
34. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
35. Membranous CD24 drives the epithelial phenotype of pancreatic cancer.
Lubeseder-Martellato C; Hidalgo-Sastre A; Hartmann C; Alexandrow K; Kamyabi-Moghaddam Z; Sipos B; Wirth M; Neff F; Reichert M; Heid I; Schneider G; Braren R; Schmid RM; Siveke JT
Oncotarget; 2016 Aug; 7(31):49156-49168. PubMed ID: 27203385
[TBL] [Abstract][Full Text] [Related]
36. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
[TBL] [Abstract][Full Text] [Related]
37. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.
Erkan M; Reiser-Erkan C; Michalski CW; Deucker S; Sauliunaite D; Streit S; Esposito I; Friess H; Kleeff J
Neoplasia; 2009 May; 11(5):497-508. PubMed ID: 19412434
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells.
Gunda V; Kumar S; Dasgupta A; Singh PK
Methods Mol Biol; 2018; 1742():95-105. PubMed ID: 29330793
[TBL] [Abstract][Full Text] [Related]
39. SMAD4 and TGFβR2 expression in pancreatic ductal carcinoma.
Văduva IA; Mărgăritescu C; Georgescu CV; Enache AO; Pădureanu R; Săftoiu A; Pirici D
Rom J Morphol Embryol; 2019; 60(3):803-809. PubMed ID: 31912090
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
Topalovski M; Hagopian M; Wang M; Brekken RA
J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]